Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

Title
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
Authors
Keywords
Immune checkpoint inhibitor, Immune-related adverse event, Nivolumab, Non–small cell lung cancer, Programmed cell death ligand 1
Journal
Journal of Thoracic Oncology
Volume 12, Issue 12, Pages 1798-1805
Publisher
Elsevier BV
Online
2017-09-20
DOI
10.1016/j.jtho.2017.08.022

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now